Two-year data indicates bimekizumab maintains high levels of psoriatic skin clearance
Study results indicate that maintenance doses of bimekizumab (320 mg) every four or eight weeks can maintain high levels of skin...
top of page
it's where dermatology lives
Featured Posts
bottom of page